Community-Acquired Pneumonia: all 325 studies
Page 2 of 4. Open to participants first (78), then studies with results posted, then the rest; newest registration first within each.
- A Safety and Tolerability Study of Doripenem Compared With Cefepime in Hospitalized Children With Bacterial PneumoniaTerminatedNCT01110421Phase 3Results posted
- Evaluation of the Treatment With Klacid®SR in Patients With Lower Respiratory Tract InfectionCompletedNCT01108185Results posted
- Non-Interventional Open Label Prospective Observational Comparative Study On Evaluation Of Compliance Of The Empiric Treatment With Azithromycin SR Versus Amoxiclav 1000 Mg In Adult Patients With Mild To Moderate Community Acquired PneumoniaTerminatedNCT01032694Results posted
- The Study Of Azithromycin Switch Therapy For Treatment Of Community Acquired Pneumonia (CAP)CompletedNCT00809328Phase 3Results posted
- Safety and Efficacy Study of Oxazolidinone to Treat PneumoniaCompletedNCT00640926Phase 2Results posted
- Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired PneumoniaCompletedNCT00621504Phase 3Results posted
- Helmet Continuous Positive Airway Pressure Versus Oxygen Venturi in Acute Respiratory Failure in CAP: CAPOVeRSOTerminatedNCT00603564Not applicableResults posted
- Comparative Study of Ceftaroline vs. Ceftriaxone in Adults With Community-Acquired PneumoniaCompletedNCT00509106Phase 3Results posted
- COMPAS (Clinical Otitis Media & Pneumonia Study): Pneumonia & Acute Otitis Media (AOM ) Efficacy Study of the Pneumococcal Conjugate VaccineCompletedNCT00466947Phase 3Results posted
- Inhaled Lexofloxacin vs Usual Care for Treatment of Community-Acquired PneumoniaActive, not recruitingNCT07843017Phase 2/3
- Nogapendekin Alfa-Inbakicept and iNKT Cells for Critically Ill Adults With Severe Community-Acquired Pneumonia (With or Without Sepsis/ARDS)WithdrawnNCT07492888Phase 2
- Study of Nogapendekin Alfa Inbakicept and iNKT Cells in Critically Ill Adults With Severe Community-Acquired PneumoniaWithdrawnNCT07492875Phase 3
- Derivation and Validation of the Risk Evaluation Score for Pneumonia Involving Resistant Entities (RESPIRE)CompletedNCT07425561
- Lower Respiratory Tract Infections Managed in Primary Care in FranceCompletedNCT07416266
- Pneumococcal Community-Acquired Pneumonia Requiring Hospitalization Among Colombian AdultsCompletedNCT07354425
- HVNI vs CPAP in Children With Acute Respiratory DistressCompletedNCT07336121Not applicable
- Amoxicillin/Clavulanic Acid Susceptibility in Acute Community-acquired Pneumonia Requiring Intensive Care ManagementCompletedNCT07322549
- A Study to Learn How Effective is PCV20 to Help Stop Adults Who Have a Higher Chance of Getting PneumoniaActive, not recruitingNCT07251465
- Reducing Antibiotic Use by Implementation of Stewardship in Primary and Urgent CareActive, not recruitingNCT07217002
- Evaluation of Physical Capacity and Energy Requirements in Patients With Hypoxemic Acute Respiratory FailureActive, not recruitingNCT07178483
- Kinetics and Metabolism of Nicotinamide Provided as a Dietary SupplementationCompletedNCT07156929Not applicable
- Local Antibiotic Delivery for Community Acquired PneumoniaActive, not recruitingNCT06859450Phase 2/3
- Efficacy and Safety of Faropenem in Bangladeshi Adult Patients With Community-Acquired Bacterial Pneumonia (CABP)CompletedNCT06804096Phase 4
- A Study to Learn About How Well the Prevnar 20 Vaccine Works for Pneumonia in People Who Are 65 Years and OlderActive, not recruitingNCT06782282
- How Does Medical Clown Intervention Affect the Length of Hospitalization in Children With PneumoniaCompletedNCT06750029Not applicable
- The Effect of Adjunct Vitamin a on Community-Acquired Pneumonia in Southern Iranian Children: a Randomized Clinical TrialCompletedNCT06677684Not applicable
- Electrical Impedance Imaging Techniques in Guiding the Use of Chest Physiotherapy in Patients with PneumoniaCompletedNCT06642701Not applicable
- The Optimal Antibiotic Treatment Duration for Community-acquired Pneumonia in Adults Diagnosed in General Practice in Denmark (CAP-D)CompletedNCT06295120Phase 4
- Effectiveness of the PCV13 in Older Thai AdultsCompletedNCT06279624
- Clinical Trial of the Efficacy and Safety of Raphamin in Combined Treatment of Community-acquired PneumoniaCompletedNCT06263881Phase 3
- The Effect of Focused Lung Ultrasonography on Antibiotic Prescribing in General PracticeCompletedNCT06210282Not applicable
- High-dose Inhalations of Nitric Oxide in the Treatment of PneumoniaActive, not recruitingNCT06170372Not applicable
- Improving Short Course Treatment for Common Pediatric InfectionsCompletedNCT06087809Not applicable
- Safety and Efficacy of AON-D21 in Severe Community-Acquired Pneumonia.CompletedNCT05962606Phase 2
- Discharge Stewardship in Children's HospitalsCompletedNCT05826873Not applicable
- Use of Presepsin as a Marker for Immunotherapy Administration in PneumoniaCompletedNCT05785442Phase 2
- Supportive Treatment and Antibiotics for Mild Pediatric PneumoniaCompletedNCT05726253Early Phase 1
- The Effect of Huashibaidu Granule on Community-acquired Pneumonia in ChildrenStatus unknownNCT05711017Not applicable
- Efficacy of Intravenous Amboxol Hydrochloride as an Adjunct Therapy for Severe Pneumonia in Critically Ill PatientsCompletedNCT05663905Phase 4
- Inventory of the Management of Acute Community-acquired Pneumonia in Strasbourg University HospitalsStatus unknownNCT05661513
- Impact on the Use of Antibiotics of a Multimodal Algorithm for the Diagnosis and Management of Acute Community-acquired Pneumonia in the Emergency RoomCompletedNCT05657275Not applicable
- A 2-Part First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of CMTX-101TerminatedNCT05629741Phase 1
- Diagnostic Performance and Impact of a Multiplex PCR Pneumonia Panel in ICU Patients With Severe Pneumonia.CompletedNCT05624684
- Correlation Between Antibiotic Resistance and Incidence of Sepsis in Community Acquired PneumoniaStatus unknownNCT05606627
- Reducing Antimicrobial Overuse Through Targeted Therapy for Patients With Community-Acquired PneumoniaCompletedNCT05568654Not applicable
- Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 PneumoniaTerminatedNCT05531149Phase 3
- Neuromuscular Electrical Stimulation in COPD/Community Acquired PneumoniaCompletedNCT05452226Not applicable
- Study of Ingaron's Effect on Efficacy and Resistance to Antibiotics in Community-acquired PneumoniaCompletedNCT05395702Not applicable
- A Retrospective Study to Evaluate the Predictability of Abnormal Arterial Blood Gas Measurements Through Novel Observations of Continuous Trends in Electronically Measured Respiratory Rate in a Mixed Cohort of Respiratory Compromised PatientsStatus unknownNCT05384314
- POCT PCT in Outpatient LRTICompletedNCT05380869Not applicable
- Serotype Distribution in Hospitalized Adult With Pneumococcal Community Acquired Pneumonia in FranceCompletedNCT05380193
- Postural Drainage and PEP Technique in Community Acquired PneumoniaCompletedNCT05356494Not applicable
- A Pharmacokinetics and Safety Study of Augmentin ES-600 in Children With CAP and ABRSWithdrawnNCT05340257Phase 2
- mNGS -Guided Antimicrobial Treatment in Early Severe Community-Acquired Pneumonia Among Immunocompromised PatientsStatus unknownNCT05290454Not applicable
- Oral Nemonoxacin in Treating Elderly Patients With CAPCompletedNCT05133752Phase 4
- PCV13 Impact on Pneumococcal Nasopharyngeal Carriage StudyActive, not recruitingNCT05114902
- Promoting Optimal Treatment for Community-acquired Pneumonia in the Emergency Room (PIONEER)CompletedNCT05114161Not applicable
- A Pre-post Intervention Study Evaluating Home-based Management of Patients With COPD or CAPWithdrawnNCT05009485Not applicable
- A Retrospective, Real-world Study of ELP Used in the Expectorant Treatment of Community-acquired PneumoniaStatus unknownNCT05002192
- Two Different Ventilatory Strategies in Acute Respiratory Distress Syndrome Due to Community-acquired PneumoniaTerminatedNCT04972318Not applicable
- Clinical, Molecular and Functional Biomarkers for PROgnosis, Pathomechanisms and Treatment Strategies of COVID-19 (PROVID) - (PROVID-CAPNETZ)Status unknownNCT04952337
- Pneumococcal Nasopharyngeal Colonization as Predictor of Community-Acquired Pneumonia (CAP) in Adults With Chronic Diseases.Status unknownNCT04944719
- Point-of-Care Multiplex for Adult Patients With Severe Community-acquired PneumoniaStatus unknownNCT04835818Not applicable
- Use of a Rapid Diagnostic Test for Antibiotic De-escalation in Severe Community Acquired PneumoniaWithdrawnNCT04781829Not applicable
- Advanced Diagnostics for Enhanced QUality of Antibiotic Prescription in Respiratory Tract Infections in Emergency RoomsCompletedNCT04781530Not applicable
- Anti-inflammatory Action of Oral Clarithromycin in Community-acquired PneumoniaCompletedNCT04724044Phase 3
- TCM Syndrome Differentiation Treatment on Discharged Elderly Patients With CAPStatus unknownNCT04702074Not applicable
- Accuracy of Lung Injury Biomarkers in the Initial Investigation of Patients With Suspected PneumoniaCompletedNCT04686331
- Clinical Characteristics of Acutely Hospitalized Adults With Community-acquired- PneumoniaCompletedNCT04681963
- The Impact of Air Pollution on the Consumption of Antimicrobials in the General PopulationStatus unknownNCT04662047
- A Clinical Safety Study on AT-100 in Treating Adults With Severe COVID-19 Infection or Severed Community Acquired PneumoniaTerminatedNCT04659122Phase 1
- Corticosteroids in Community Acquired PneumoniaWithdrawnNCT04652414Phase 2
- A Phase 2 Study Evaluating Efficacy, Safety and Tolerability of Different Doses and Regimens of Allocetra-OTS for the Treatment of Organ Failure in Adult Sepsis PatientsCompletedNCT04612413Phase 2
- Efficacy and Safety of Trimodulin in Subjects With Severe COVID-19CompletedNCT04576728Phase 2
- Study of a Possible Respiratory Degradation Prognosis Caused by Biomarkers in Severe Forms of COVID-19 PneumoniaTerminatedNCT04505605
- Energy Supply in Athletes and Untrained Persons With Bronchopulmonary DiseasesStatus unknownNCT04415827Not applicable
- LDCT in COVID-19 Pneumonia: a Prospective Moscow StudyCompletedNCT04379531Not applicable
- Pharmacokinetics and Pleural Fluid Penetration of Amoxicillin and Clavulanic Acid in Patients With Pleural InfectionsCompletedNCT04350502Not applicable
- EVALUATION OF THE EFFICACY OF THE HYDROXYCHLOROQUINE-AZITHROMYCIN COMBINATION IN THE IN THE PREVENTION OF COVID-19 RELATED SDRAWithdrawnNCT04347512Phase 3
- Molecular Biomarkers for SepsisTerminatedNCT04280354
- Community-Acquired Pneumonia Diagnosis Using Lung Ultrasound in Emergency Room AdultsTerminatedNCT04210102Not applicable
- Pharmacokinetics of High-dose Ceftobiprole in Community-acquired Pneumonia Under Mechanical Ventilation.CompletedNCT04171674Not applicable
- Impact of Comprehensive Molecular Tests on Antimicrobial Stewardship in Community-acquired PneumoniaTerminatedNCT04158492Not applicable
- Evaluation the Clinical Value of Xiyanping Injection in the Treatment of Community-acquired Pneumonia in ChildrenStatus unknownNCT04158310
- Assessing Effectiveness of Community Acquired Pneumonia Treatment by Continuous Pneumonia Severity ScoreStatus unknownNCT04135183Not applicable
- Mycoplasma Infection Rate and Macrolides Resistance in Children With Acute Respiratory Tract InfectionStatus unknownNCT04126304
- Physical Training During Hospital Admission With Community-Acquired PneumoniaStatus unknownNCT04094636Not applicable
- Shortened Antibiotic Treatment of 5 Days in Community-Acquired PneumoniaCompletedNCT04089787Phase 4
- Effect of Albumin Administration in Hypoalbuminemic Hospitalized Patients With Community-acquired Pneumonia.TerminatedNCT04071041Phase 3
- pedCAPNETZ - Community Acquired Pneumonia (CAP) in Childhood and AdolescenceStatus unknownNCT04047108
- Diagnosis of Mycoplasma Pneumoniae Infection With Detection of Specific Antibody-secreting Cells in Community-acquired Pneumonia (CAP) Patients of the Randomised Placebo-controlled Multi-centre Effectiveness Trial of Adjunct Betamethasone TherapyStatus unknownNCT04043325
- An Observational Study to Assess the Prevalence and Outcomes of Primary Pulmonary Coccidioidomycosis in Persons Aged > / = 14 Years Presenting With Community Acquired Pneumonia (CAP) in Endemic Areas (SAnds-PPC)CompletedNCT03908632
- Incidence and Prognostic Implication of Acute CV Events in Patients Hospitalized for CAP in Internal Medicine Units.CompletedNCT03798457
- The Effect of Protein Supplement on Lean Body Mass in Patients With PneumoniaCompletedNCT03774953Not applicable
- Corticosteroids and Myocardial Injury in CAP (COLOSSEUM TRIAL)Status unknownNCT03745664Phase 3
- Multicenter Epidemiologic Study of Severe Community Acquired Pneumonia in ChinaStatus unknownNCT03728816
- Determination of the Utility of Pfizer's Pneumococcal Urine Antigen Test in Children 5 Years of Age or Younger With Community Acquired Pneumonia in GuatemalaCompletedNCT03696303
- Clinical Study of Anerning Particle for the Treatment of Childhood Community-acquired PneumoniaStatus unknownNCT03675178Phase 4
- Exhaled Breath Metabolomic Biomarkers in the Acutely Breathless PatientCompletedNCT03672994
- Adequate Duration of Antibiotic Treatment in Community-acquired Pneumonia With High Risk Class and Adequate Initial Clinical ResponseStatus unknownNCT03609099Phase 4